Alphabet Inc. 13F Holdings
Alphabet Inc.'s holdings from its Form 13F-HR filing for the quarter ended June 30, 2026, compared with the previous quarter (March 31, 2026). 13F filings list the long U.S. equity positions held by institutional investment managers with over $100 million under management.
Quarter
Q2 2026
Reported 13F value
$99.1B
Largest holding
Space Exploration Techn Corp (class A COM STK)
Biggest Buys (Q2 2026)
| Security | Change | Value of change | % of portfolio |
|---|---|---|---|
| SPACE EXPLORATION TECHN CORP (CLASS A COM STK) | New position | $94.2B | 95.05% |
| PARABILIS MEDICINES INC | New position | $134.6M | 0.14% |
| FERVO ENERGY CO (CL A COM) | New position | $51.5M | 0.05% |
Biggest Sells (Q2 2026)
| Security | Change | Value of change | % of portfolio |
|---|---|---|---|
| REVOLUTION MEDICINES INC | -345,900 sh | -$49.2M | 0.56% |
| MONTE ROSA THERAPEUTICS INC | -311,800 sh | -$6.3M | 0.01% |
| RELAY THERAPEUTICS INC | -154,100 sh | -$2.2M | 0.03% |
| ETHOS TECHNOLOGIES INC (CL A) | -147,600 sh | -$2.2M | 0.07% |
| TENAYA THERAPEUTICS INC | Sold out | -$632K | 0.00% |
Top 28 Holdings
| Security | Value | % of portfolio | Change in shares |
|---|---|---|---|
| SPACE EXPLORATION TECHN CORP (CLASS A COM STK) | $94.2B | 95.05% | New |
| PLANET LABS PBC (COM CL A) | $1.2B | 1.18% | +0.00% |
| AST SPACEMOBILE INC (COM CL A) | $794.7M | 0.80% | +0.00% |
| CME GROUP INC | $769.4M | 0.78% | +0.00% |
| ARM HOLDINGS PLC (SPONSORED ADS) | $695.2M | 0.70% | +0.00% |
| REVOLUTION MEDICINES INC | $551.8M | 0.56% | -10.51% |
| FRESHWORKS INC (CLASS A COM) | $164.0M | 0.17% | +0.00% |
| PARABILIS MEDICINES INC | $134.6M | 0.14% | New |
| TEMPUS AI INC (CL A) | $89.9M | 0.09% | +0.00% |
| GITLAB INC (CLASS A COM) | $83.2M | 0.08% | +0.00% |
| UIPATH INC (CL A) | $76.5M | 0.08% | +0.00% |
| ETHOS TECHNOLOGIES INC (CL A) | $65.7M | 0.07% | -3.91% |
| PRIME MEDICINE INC | $61.1M | 0.06% | +0.00% |
| FERVO ENERGY CO (CL A COM) | $51.5M | 0.05% | New |
| PAYPAY CORP (SPONSORED ADS) | $44.8M | 0.05% | +0.00% |
| MAZE THERAPEUTICS INC | $41.4M | 0.04% | +0.00% |
| RELAY THERAPEUTICS INC | $26.4M | 0.03% | -9.85% |
| BRIDGEBIO ONCOLOGY THERAPEUT (COM NEW) | $21.5M | 0.02% | +0.00% |
| OSCAR HEALTH INC (CL A) | $13.7M | 0.01% | +0.00% |
| BEAM THERAPEUTICS INC | $11.0M | 0.01% | +0.00% |
| VERA THERAPEUTICS INC (CL A) | $10.4M | 0.01% | +0.00% |
| SANA BIOTECHNOLOGY INC | $9.8M | 0.01% | +0.00% |
| MONTE ROSA THERAPEUTICS INC | $9.0M | 0.01% | -45.57% |
| LYELL IMMUNOPHARMA INC (COM NEW) | $4.1M | 0.00% | +0.00% |
| FIGMA INC (CLASS A COM STK) | $3.9M | 0.00% | +0.00% |
| SPERO THERAPEUTICS INC | $2.0M | 0.00% | +0.00% |
| HYPERFINE INC (COM CL A) | $1.2M | 0.00% | +0.00% |
| AUTOLUS THERAPEUTICS PLC (SPON ADS) | $1.1M | 0.00% | +0.00% |
Values are as reported in the filing, adjusted for stock splits. Ranked by market value; options and other non-equity positions may be included where the filing lists them.
Similar-Sized Managers
- Pictet Asset Management Holding SA · $104.7B
- HighTower Advisors, LLC · $103.2B
- Mackenzie Financial Corp · $100.0B
- Sanders Capital, LLC · $99.8B
- BNP PARIBAS ASSET MANAGEMENT Holding S.A. · $99.8B
- Focus Partners Wealth · $97.6B
- Mariner, LLC · $95.2B
- Prudential Financial Inc · $91.8B
- US Bancorp \DE · $91.6B
- Point72 Asset Management, L.P. · $90.7B